G3BP stress granule assembly factor 2 (G3BP2) is a multidomain RNA-binding protein that serves as a core nucleator of stress granules (SGs)—membraneless assemblies that transiently sequester translation machinery and mRNA in response to cellular stress. G3BP2 contains five critical structural motifs: the NTF2 domain for protein dimerization and nuclear transport, an acidic-rich region, multiple proline-rich (PxxP) motifs mediating protein interactions, an RNA recognition motif (RRM) for binding RNA, and an RGG domain important for protein and RNA interactions. G3BP2 regulates mRNA stabilization/degradation, nucleocytoplasmic trafficking, antiviral defense, and cellular responses to stress. Aberrant expression or mutation of G3BP2 is implicated in a variety of cancers, cardiovascular disorders, and viral pathogenesis. While not yet the focus of approved therapeutics, G3BP2 represents an emerging target for drug discovery in oncology and infectious disease.
Other names
Ras GTPase-activating protein-binding protein 2KIAA0660G3BP-2GAP SH3 domain-binding protein 2Ras-GTPase activating protein SH3 domain-binding protein 2GTPase activating protein (SH3 domain) binding protein 2
02
Mechanism of action
Inhibition of stress granule assembly by blocking key protein-protein or RNA interactions (e.g., targeting FGDF-binding pocket of the NTF2 domain)
Disruption of nucleocytoplasmic shuttling or phase separation
Modulation of mRNA decay and translation in stress response pathways
03
Biological functions
Stress granule assemblyRNA stabilization and metabolismSubcellular localization (nucleocytoplasmic shuttling)Protein-protein interactionsRegulation of cell growth, differentiation, and migrationmRNA decay and translation regulationAntiviral defense
04
Disease associations
Cancer (including breast, lung, and prostate cancer)Cardiovascular disease (e.g., cardiac hypertrophy, atherosclerosis)Infection (notably viral infections—modulates viral replication)Other (possibly inflammation)
05
Safety considerations
Broad cellular roles suggest potential toxicity with systemic inhibitors (impacts cell viability, stress response, protein translation, and antiviral defense)Disruption of normal stress granule function may exacerbate cell death or impair physiological stress responsesUnknown off-target effects—limited clinical experience with direct G3BP2 inhibitors
06
Interacting drugs
No clinically approved drugs directly targeting G3BP2 as of now, but some experimental compounds or peptides that disrupt G3BP2 interactions (e.g., FGDF motif-containing peptides, viral protein fragments)
07
Biomarkers
Elevated G3BP2 expression in tumors (e.g., breast, lung, prostate) can predict disease progression or serve as a prognostic biomarkerG3BP2 levels or stress granule formation status may serve as a readout in infection or inflammatory models
Beyond the preview
Go deeper on G3BP stress granule assembly factor 2 (G3BP2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on G3BP stress granule assembly factor 2 (G3BP2).